Microengineered transplantation of human solid tumors for in vitro studies of CAR T immunotherapy
- Source
- DataCite
- Published
- 2026
- License
- Creative Commons Zero v1.0 Universal
- Themes
- Genomics & Biotechnology, Public Health
About this dataset
Treatment of solid malignancies using chimeric antigen receptor (CAR) T cells remains a significant challenge, but current efforts to advance this therapy are challenged by our limited capacity to probe and understand cancer-immune interactions in human solid tumors. Here, we present a microengineered platform for in vitro modeling of malignant solid tumors during CAR T therapy. This system makes it possible to vascularize human tumor explants and perfuse them with blood-borne immune cells in a controlled manner. We first present a microphysiological model of human lung adenocarcinomas infused with CAR-T cells and show how this system can be used to simulate, visualize, and interrogate tumor-directed trafficking and effector function of CAR T cells. We then demonstrate the proof-of-principle of testing a chemokine-directed CAR T cell engineering strategy in a model of malignant...
How the data was collected
The source metadata does not specify a detailed collection methodology. Provenance: this record was harvested from DataCite and published by Dryad. Consult the original source for methodological details, temporal coverage, and access constraints.